Search Results

The ABC ("Arterial Blood Collection") In-Line Blood Sampling Kit is a closed blood sampling system used in conjunction with continuous blood pressure monitoring in a critical care setting. The ABC Kit is designed for use with all disposable and reusable pressure transducers and for connection to central line catheters and arterial catheters. The ABC Kit is used for the drawing and retention within the line of heparinized blood from the catheter/cannula, allowing undiluted blood samples to be drawn from an in-line sampling site. At the completion of sample drawing, the mixed heparin/blood solution is reinfused into the patient to reduce fluid loss.

The ABC ("Arterial Blood Collection") In-Line Blood Sampling Kit is a closed blood sampling system used in conjunction with continuous blood pressure monitoring in a critical care setting. The ABC Kit is designed for use with all disposable and reusable pressure transducers and for connection to central line catheters and arterial catheters. The ABC Kit is used for the drawing and retention within the line of heparinized blood from the catheter/cannula, allowing undiluted blood samples to be drawn from an in-line sampling site. At the completion of sample drawing, the mixed heparin/blood solution is reinfused into the patient to reduce fluid loss.

The provided text is a 510(k) summary for a medical device called the "ABC In-Line Blood Sampling Kit." This document is a regulatory submission for premarket notification to the FDA, not a study report detailing performance acceptance criteria and validation studies in the way you've requested.

Therefore, I cannot extract the information you've asked for (acceptance criteria, study details, sample sizes, expert qualifications, etc.) for the following reasons:

• Clinical Performance Study Not Described: The document focuses on demonstrating substantial equivalence to a predicate device (Baxter VAMP™ blood sampling system cleared under 510(k) K/885281) for regulatory clearance. It does not describe an independent clinical performance study with acceptance criteria and results.
• Focus on Substantial Equivalence: The primary points made are about the device's function, materials, and substantial equivalence to the predicate, with a brief mention of pressure monitoring frequency response being "essentially equivalent." This is a regulatory comparison, not a detailed performance study with defined metrics.
• No Mention of AI or Algorithm Performance: The device is an "In-Line Blood Sampling Kit," a physical medical device. There is no mention of an algorithm, AI, or software component that would require the kind of performance metrics you've outlined (e.g., standalone performance, MRMC studies, ground truth establishment methods for a machine learning model).

To summarize, the document does not contain the information required to answer your prompt because it is a regulatory submission demonstrating substantial equivalence of a physical medical device, not a report on a clinical or AI performance study.

Ask a specific question about this device